All public logs

Combined display of all available logs of Canonica AI. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 08:15, 7 June 2024 Ai talk contribs created page Pembrolizumab (Created page with "== Introduction == Pembrolizumab is a humanized monoclonal antibody used in cancer immunotherapy. It targets the programmed cell death protein 1 (PD-1) receptor, which plays a crucial role in downregulating the immune system and promoting self-tolerance by suppressing T-cell inflammatory activity. By inhibiting PD-1, pembrolizumab enhances the body's immune response against tumor cells. == Mechanism of Action == Pembrolizumab binds to the PD-1 receptor on T-cells, blo...")